An interventional study of Therapist Triage in Inflammatory Arthritis, sponsored by Sunnybrook Health Sciences Centre. Completed. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2016-06-30.
Sponsored by Sunnybrook Health Sciences Centre · Not applicable and Interventional
There is accumulating evidence that early treatment leads to better outcomes for patients with inflammatory arthritis (IA). Triage, which is the process of identifying the urgency of a patient's disease state efficiently and correctly, may facilitate early referral to a rheumatologist. Several studies have suggested that placing allied health professionals (occupational therapists, physical therapists, nurses, etc.) in a triage roll may reduce wait time for patients with suspected IA. The goal of this investigation will be to demonstrate the system-level impact of an Arthritis Society extended role occupational therapist (OT) or physical therapist (PT) working in a triage role in improving access to rheumatologists for people with IA. In this study two groups will be observed: intervention and "usual care" as determined by historical chart review. Wait times will be compared between both groups.
3,554 studies on the registry are indexed under Arthritis; 318 are open to participants now.
This study's enrollment of 295 is above the median of 90 across 2,377 interventional studies indexed under Arthritis.
Browse Arthritis studies →Sunnybrook Health Sciences Centre is the lead sponsor of 566 studies on the registry; 134 are open to participants now.
Of its 6 completed or terminated interventional studies of FDA-regulated products, 2 (33%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
All subjects in this group will be triaged by an extended role occupational or physical therapist prior to their visit with the rheumatologist.
Other: Therapist Triage
An extended role occupational or physical therapist will triage each subject in the study to determine the urgency of their case and how soon they need to see the rheumatologist.
Time to first visit with the rheumatologist (wait time)
Time frame: 3 months
Time to diagnosis
Time frame: 3 months
Time to treatment (disease-modifying antirheumatic drug)
Time frame: 3 months
No study locations are listed for this record.
This study is completed, as verified in Jun 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Sunnybrook Health Sciences Centre